Cavitation Technologies Latest Water Treatment U.S. Patent is Approved
CHATSWORTH, CA, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via – Cavitation Technologies, Inc. (OTCQB: ) (BERLIN: ) announced that U.S. Patent Application No. 17/066,040, Entitled: 'APPARATUS FOR GENERATING CAVITATION IN A LIQUID' was approved by the United States Patent and Trademark Office (USTPO). This is a high-volume fluid processing multistage cavitation system.
Cavitation Technologies, Inc. (CTI) already holds several patents related to treatment of water in beverages and contaminated industrial water. This newly approved patent relates to a multi-stage cavitation device featured with an electrocoagulation system. The amalgamation of multi-stage cavitation and electrocoagulation devices, coupled with air floatation units enables contaminants in liquid to attach to air bubbles and float to the liquid's surface where they can be easily removed as sludge. The treated fluid is then passed through a final filtration system. This patented processing system is related to some of CTI's previous patents including, 'flow-through cavitation-assisted rapid modification of beverage fluids' and 'system and methods for the purification of drinking water, ethanol, and other alcoholic liquids/beverages containing impurities.'
Roman Gordon, Global Technology Manager, stated, "Industrial water treatment requires large volume processing. With this new issued patent, our engineers have developed a high-volume reactor system that processes up to 35,000 barrels/day of water. Our initial commercial water treatment results in the oil and gas industry have been successful and we feel that refineries and plants processing contaminated water and liquids may experience additional benefits through the implementation of our newly patented system. We are starting to see the reopening of the oil and gas industry in the US and anticipate a resumption of commercial production in the near future"
This is a new addition to the Company's 40 patents and applications portfolio that consists of 21 US issued and 6 US pending patents as well as 7 foreign issued and 6 foreign pending patents.
About Cavitation Technologies, Inc.
Founded in 2007, the company designs and manufactures innovative flow-through devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, water treatment, and alcoholic beverage enhancement. The company's patented Nano Reactor® systems and various technologies have over 40 patents issued and filed both domestically and abroad. .
Follow us on Twitter for real time updates:
Like us on Facebook to receive live feeds updates:
Forward-Looking Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as ''may,'' ''should,'' ''potential,'' ''continue,'' ''expects,'' ''anticipates,'' ''intends,'' ''plans,'' ''believes,'' ''estimates,'' and similar expressions, and include statements such as, the resumption of commercial production being anticipated in the near future. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a variety of factors including, among others, our ability to perform the installation as anticipated, the state of the economy, the competitive environment and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward-looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Jessica Steidinger
